[
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
[og_img]
https://www.investing.com/news/press-releases/akero-therapeutics-and-histoindex-present-new-analyses-of-phase-2b-harmony-trial-in-oral-and-poster-presentations-at-the-easl-congress-2025-93CH-4037701
Investing.com
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Related articles